ADC Therapeutics SA (ADCT) insider trading
Every open-market stock purchase and sale by ADC Therapeutics SA executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Insiders bought $15M over the last 12 months (1 buy).
- Insiders sold $19.6M over the last 12 months (1 sale).
- Last insider buy: Redmile Group LLC (10% owner), $15M, 11 months ago.
Last 12 months: insiders bought $15M (1 buy) and sold $19.6M (1 sale). Last close $1.10 on Jun 10, 2026.
Recent ADCT insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Jun 3, 2026 | Ron Squarer (Director) | Sold (not open market) | $46.8K |
| Jun 3, 2026 | Timothy Coughlin (Director) | Sold (not open market) | $38.8K |
| Jun 3, 2026 | Jean-Pierre Bizzari (Director) | Sold (not open market) | $38.8K |
| Jun 3, 2026 | Victor Sandor (Director) | Sold (not open market) | $38.8K |
| Jun 3, 2026 | Robert Azelby (Director) | Sold (not open market) | $38.8K |
| Jun 3, 2026 | Viviane Monges (Director) | Sold (not open market) | $8K |
| Jun 3, 2026 | Peter Hug (Director) | Sold (not open market) | $6.6K |
| Jun 1, 2026 | Ron Squarer (Director) | Bought (not open market) | — |
| Jun 1, 2026 | Timothy Coughlin (Director) | Bought (not open market) | — |
| Jun 1, 2026 | Jean-Pierre Bizzari (Director) | Bought (not open market) | — |
| Jun 1, 2026 | Peter Hug (Director) | Bought (not open market) | — |
| Jun 1, 2026 | Viviane Monges (Director) | Bought (not open market) | — |
| Jun 1, 2026 | Victor Sandor (Director) | Bought (not open market) | — |
| Jun 1, 2026 | Robert Azelby (Director) | Bought (not open market) | — |
| Apr 2, 2026 | Redmile Group LLC (10% owner) | Sold | $8.6M |
| Apr 2, 2026 | Redmile Group LLC (10% owner) | Sold | $8.3M |
| Apr 1, 2026 | Redmile Group LLC (10% owner) | Sold | $643K |
| Apr 1, 2026 | Redmile Group LLC (10% owner) | Sold | $617K |
| Mar 31, 2026 | Redmile Group LLC (10% owner) | Sold | $736K |
| Mar 31, 2026 | Redmile Group LLC (10% owner) | Sold | $707K |
| Feb 13, 2026 | Ameet Mallik (CEO) | Bought (not open market) | $3.6M |
| Feb 13, 2026 | Peter J Graham (C-suite exec) | Bought (not open market) | $1.2M |
| Feb 13, 2026 | Mohamed Zaki (C-suite exec) | Bought (not open market) | $1.1M |
| Feb 13, 2026 | Jose Carmona (CFO) | Bought (not open market) | $1.1M |
| Feb 13, 2026 | Ameet Mallik (CEO) | Sold (not open market) | $412K |
Who's trading ADCT
- Jean-Pierre Bizzari, Director: other filings, last Jun 3, 2026
- Viviane Monges, Director: other filings, last Jun 3, 2026
- Ron Squarer, Director: other filings, last Jun 3, 2026
- Timothy Coughlin, Director: other filings, last Jun 3, 2026
- Victor Sandor, Director: other filings, last Jun 3, 2026
- Robert Azelby, Director: other filings, last Jun 3, 2026
- Peter Hug, Director: other filings, last Jun 3, 2026
- Redmile Group LLC, 10% owner: bought $15M (1 buy), sold $19.6M (6 sales), last Apr 2, 2026
- Mohamed Zaki, C-suite exec: other filings, last Feb 13, 2026
- Jose Carmona, CFO: other filings, last Feb 13, 2026
- Peter J Graham, C-suite exec: other filings, last Feb 13, 2026
- Lisa Michelle Kallebo, C-suite exec: other filings, last Feb 13, 2026
- Ameet Mallik, CEO: other filings, last Feb 13, 2026
Get free alerts when an insider at ADC Therapeutics SA files a new trade →